文献速递外周血管介入US

超声引导下药物机械溶栓与血管成形术治疗急性血栓性人工血管动静脉通路:单中心154例手术的5年经验

Ultrasound-Guided Pharmacomechanical Thrombolysis and Angioplasty for Treatment of Acute Thrombotic Prosthetic Arteriovenous Access: 5-Year Experience with 154 Procedures in a Single Center.
PubMed 文献 · Ultrasound Med Biol · 2018-08-13

研究总结2012年12月至2016年10月单中心114例急性血栓性人工血管动静脉通路患者行超声引导下药物机械溶栓与血管成形术的经验,共154例次手术,平均随访20.7±9.1个月。技术成功率91.6%,临床成功率97.4%,术后3、6、12、24个月辅助初级通畅率分别为90.8%、78.8%、66.3%、50.9%,次级通畅率分别为96.3%、94.5%、90.6%、85.4%。

要点

  • 超声引导下药物机械溶栓与血管成形术治疗急性血栓性人工血管动静脉通路的技术成功率为91.6%,临床成功率为97.4%。
  • 术后24个月辅助初级通畅率为50.9%,次级通畅率为85.4%,需密切监测并及时干预以维持长期通畅。
  • 该方法在超声引导下成功完成,避免辐射损伤和对比剂使用,成功率与放射引导相似。

核心结论

  • 超声引导下药物机械溶栓与血管成形术治疗急性血栓性人工血管动静脉通路可行,成功率与放射引导相似,可避免辐射损伤和对比剂使用,但需密切监测并及时干预以确保长期通畅。

研究设计与样本

  • 单中心回顾性总结,2012年12月至2016年10月纳入114例急性血栓性人工血管动静脉通路患者,共行154例次超声引导下药物机械溶栓与血管成形术,术后每3个月随访,平均随访20.7±9.1个月。

诊断标准与关键数值

  • 技术成功率为91.6%,临床成功率为97.4%;术后3、6、12、24个月辅助初级通畅率分别为90.8%、78.8%、66.3%、50.9%;次级通畅率分别为96.3%、94.5%、90.6%、85.4%。

临床应用与阅片要点

  • 超声引导下药物机械溶栓与血管成形术可作为急性血栓性人工血管动静脉通路的治疗选择,避免辐射和对比剂,但需密切监测并及时干预以维持长期通畅。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Pharmacomechanical thrombolysis (PMT) and percutaneous transluminal angioplasty (PTA) for the treatment of acute thrombotic prosthetic arteriovenous access (PAVA) are conventionally guided by radiography, which may cause radiation injury and requires the use of radiographic contrast media. The aim of the present study was to summarize our experience with ultrasound-guided PMT and PTA as an alternative to radiographic guidance. Between December 2012 and October 2016, 114 patients with acute thrombosis of PAVA were treated urgently with ultrasound-guided PMT and PTA to restore blood flow. The patients were followed up every 3 mo postoperatively. The 114 included patients underwent 154 episodes of ultrasound-guided PMT and PTA and were followed up for a mean of 20.7 ± 9.1 mo. The technical success rate was 91.6%, and the clinical success rate was 97.4%. Post-intervention-assisted primary patency rates at 3, 6, 12 and 24 mo were 90.8%, 78.8%, 66.3% and 50.9%, respectively. Post-intervention secondary patency rates at 3, 6, 12 and 24 months were 96.3%, 94.5%, 90.6% and 85.4%, respectively. PMT and PTA for the treatment of PAVA were performed successfully under the guidance of ultrasound with a success rate similar to that under radiographic guidance, thus avoiding radiation injury and contrast medium use, although close surveillance and timely intervention are imperative to ensure long-term patency.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Lu M, Li H, Feng J, et al. Ultrasound-Guided Pharmacomechanical Thrombolysis and Angioplasty for Treatment of Acute Thrombotic Prosthetic Arteriovenous Access: 5-Year Experience with 154 Procedures in a Single Center. Ultrasound Med Biol. 2018. PMID: 30115490. doi:10.1016/j.ultrasmedbio.2018.06.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。